Results 131 to 140 of about 155,020 (314)

What happened after the epidemic? Equine influenza surveillance sheds light on sources and seasonal risk in the United Kingdom

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background The epidemiology of equine influenza (EI) in the United Kingdom has not been systematically described since the 2019 epidemic. Objectives To summarise UK EI surveillance (2020–2024), quantify outbreak seasonality and assess movement‐related sources. Study Design Retrospective observational analysis of national surveillance and horse
Fleur Whitlock   +2 more
wiley   +1 more source

Cross‐protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Streptococcus equi subspecies zooepidemicus is a highly diverse opportunistic pathogen of horses, associated with respiratory disease and endometritis. Objectives To characterise S. zooepidemicus isolates recovered from young ponies during a natural episode of respiratory disease, and to determine if vaccination with Strangvac®, a ...
Romain Paillot   +8 more
wiley   +1 more source

Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022

open access: yes
Background: In 2022, publicly funded influenza vaccine was made available to all residents of Queensland, Australia. This study compared influenza epidemiology in 2022 with previous years (2017–2021) and estimated influenza vaccine effectiveness (VE ...
Shrestha, Ashish C   +5 more
core   +1 more source

Quadrivalent inactivated influenza vaccine (VaxigripTetra™)

open access: yes, 2017
Introduction: VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age.
Marie-Pierre Kazek-Duret   +6 more
core   +1 more source

Thermostabilization of influenza vaccine in microneedle patches

open access: yes, 2017
Vaccine delivery to the skin via microneedles confers several advantages over the traditional hypodermic needle and syringe. This work focuses on developing microneedles as a thermostable delivery method for the influenza vaccine that can be completely ...
Mistilis, Matthew Joseph
core  

Parent Preferences for Pediatric Influenza Vaccine Attributes

open access: yes, 2010
Influenza vaccine is available as an intramuscular injection or an intranasal spray for eligible children. This study was conducted to examine parents’ preferences for influenza vaccine attributes and the attributes’ relative importance regarding the ...
Victoria M. Divino   +7 more
core   +1 more source

A multiplex interactome of Ebola virus proteins reveals TM9SF2 as a cell‐surface attachment factor that promotes viral entry

open access: yesiMetaOmics, EarlyView.
This study generates a comprehensive Ebola virus (EBOV)‐human protein–protein interactome, comprising 1728 core high‐confidence interactions. Further interactome analysis revealed the potential association of EBOV glycoprotein (GP) with the host factor TM9SF2. Subsequent mechanistic investigations confirmed that TM9SF2 functions as an attachment factor
Limin Shang   +16 more
wiley   +1 more source

Analysis of influenza vaccine coverage

open access: yes, 2021
UC Berkeley led a school-based survey to measure influenza vaccine coverage in a sample of schools participating in Shoo the Flu as well as in schools in a matched comparison ...
Ben Arnold   +5 more
core  

Integrated one‐pot CRISPR‐Cas detection: Addressing strategies and future prospects

open access: yesInterdisciplinary Medicine, EarlyView.
Integrated one‐pot CRISPR‐Cas detection significantly simplifies workflows, reduces cross‐contamination risks, and shortens turnaround times, making it highly suitable for point‐of‐care testing (POCT) and resource‐limited settings. Key challenges include system compatibility issues between Cas proteins and isothermal amplification, limited multiplexing
Jian Zhou   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy